What medications should be prescribed for new hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Medication Selection for New Hypertension

For newly diagnosed hypertension, first-line therapy should include an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB), a calcium channel blocker (CCB), or a thiazide diuretic, with combination therapy often required to achieve blood pressure targets. 1, 2

Initial Treatment Algorithm

Step 1: Lifestyle Modifications

  • Implement sodium restriction, DASH diet, regular physical activity, weight management
  • Limit alcohol consumption and eliminate smoking
  • Sugar restriction (<10% of energy intake)
  • Allow maximum 3 months of lifestyle modifications alone for Stage 1 hypertension before adding medications 1

Step 2: Pharmacological Therapy Selection

  1. First-line options (choose based on patient characteristics):

    • ACE inhibitors (e.g., lisinopril) or ARBs 1, 3
    • Calcium channel blockers (dihydropyridines like amlodipine) 1, 2
    • Thiazide or thiazide-like diuretics (e.g., hydrochlorothiazide, chlorthalidone) 2
  2. Specific patient considerations:

    • Patients with elevated diastolic BP: ACE inhibitors/ARBs preferred 1
    • Black patients: CCBs or thiazide diuretics may be more effective 3
    • Patients with diabetes or CKD: ACE inhibitors/ARBs preferred 1
    • Patients with thoracic aortic disease: Consider beta-blockers 1

Step 3: Combination Therapy

  • If BP remains uncontrolled on monotherapy, add a second agent from a different class
  • Most effective combination: ACE inhibitor/ARB + CCB 1
  • Consider single-pill combinations to improve adherence 4

Step 4: Triple Therapy

  • If BP remains uncontrolled on dual therapy, add a thiazide diuretic
  • Triple combination: ACE inhibitor/ARB + CCB + thiazide diuretic 1

Step 5: Resistant Hypertension

  • Add spironolactone or beta-blocker as fourth-line agent 1

Target Blood Pressure Goals

  • General adult population: <130/80 mmHg 1, 2
  • Older adults (≥65 years): 130-139/70-79 mmHg 1
  • Very elderly (≥85 years) or frail: <140/90 mmHg 1
  • Patients with diabetes or CKD: <130/80 mmHg 1

Monitoring and Safety Considerations

  • Check blood pressure and renal function within 1-2 weeks after initiating or changing medications 1
  • Monitor for orthostatic hypotension, especially in elderly patients 1
  • For ACE inhibitors/ARBs:
    • Monitor renal function and potassium levels 1
    • Watch for cough with ACE inhibitors (consider switching to ARB if occurs)
  • For thiazide diuretics:
    • Avoid if CrCl <30 mL/min 1
    • Monitor electrolytes, particularly potassium
  • For spironolactone:
    • Use cautiously with creatinine >2.5 mg/dL 1
    • Monitor potassium closely, especially when combined with ACE/ARBs 1

Clinical Pearls and Pitfalls

  • Don't delay treatment: Uncontrolled hypertension significantly increases cardiovascular risk 2, 5
  • Avoid rapid BP reduction: In non-emergency situations, gradually lower BP to prevent organ hypoperfusion
  • Don't discontinue medications: Unless clinically indicated, as this can worsen BP control and increase cardiovascular risk 1
  • Avoid hydralazine and immediate-release nifedipine: These can cause unpredictable BP drops 6
  • Consider home BP monitoring: To confirm diagnosis and monitor treatment effectiveness 4

Special Considerations for Lisinopril

Lisinopril is an effective ACE inhibitor for hypertension with these characteristics:

  • Once-daily dosing (24-hour effect)
  • Starting dose typically 10 mg daily (range 20-40 mg/day)
  • Lower doses needed in elderly, renal impairment, or heart failure patients
  • No hepatic metabolism required (beneficial in liver disease)
  • Eliminated primarily by kidneys (dose adjustment needed in renal impairment)
  • Can be used alone or with other antihypertensives 3, 7

References

Guideline

Hypertension Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Arterial hypertension.

Lancet (London, England), 2021

Research

Hypertension.

Nature reviews. Disease primers, 2018

Research

Hypertensive crisis.

Cardiology in review, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.